| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |